Pisano Wayne

CIK 00017436113 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001743611

Recent Transactions

30 trades

Purchase
ONCOLYTICS BIOTECH INC$ONCY
Common Shares
2026-02-12$0.84/sh+30,000→ 492,414 total
Purchase
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2026-01-08$4.08/sh+5,000→ 13,498 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2025-09-25+48,800→ 48,800 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2024-09-26+34,900→ 34,900 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2023-09-28+26,100→ 26,100 total
Disposition from Tender
Provention Bio, Inc.
Common Stock
2023-04-27−7,500→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−128,981→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−33,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−22,200→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−24,000→ 0 total
Disposition to Issuer
Provention Bio, Inc.
Option to Purchase Common Stock
2023-04-27−23,000→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock Options (option to buy)
2022-12-22−20,000→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-12-22$2.60/sh+20,000→ 28,498 total
Sale
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-12-22$15.01/sh−20,000→ 8,498 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2022-09-29+23,500→ 23,500 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2022-05-17+33,000→ 33,000 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2021-09-23+24,100→ 24,100 total
Award
Provention Bio, Inc.
Stock Option (right to buy)
2021-05-12+23,000→ 23,000 total
Sale
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2020-11-12$9.90/sh−10,352→ 8,498 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2020-09-24+25,500→ 25,500 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2020-09-24+16,850→ 18,850 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units ("RSUs")
2020-09-24−16,850→ 0 total
Award
Provention Bio, Inc.
Option (right to buy)
2020-07-15+22,200→ 22,200 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units ("RSUs")
2020-06-25+16,850→ 16,850 total
Award
Provention Bio, Inc.
Option (right to buy)
2019-06-24+24,000→ 24,000 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2019-01-02+20,000→ 20,000 total
Purchase
Provention Bio, Inc.
Common Stock
2018-12-28$1.80/sh+5,000→ 7,500 total
Purchase
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2018-10-09$4.59/sh+2,000→ 2,000 total
Award
Provention Bio, Inc.
Option (right to buy)
2018-07-19+128,981→ 128,981 total
Purchase
Provention Bio, Inc.
Common Stock, par value $0.0001 per share
2018-07-19$4.00/sh+2,500→ 2,500 total

Companies

Recent Filings

Address

C/O ONCOLYTICS BIOTECH INC. 4350 EXECUTIVE DRIVE, SUITE 325

SAN DIEGO, CA, 92121

View on SEC.gov